• Interviews from Asembia's AXS24 Summit, Part 1 of 2

  • May 24 2024
  • Length: 36 mins
  • Podcast

Interviews from Asembia's AXS24 Summit, Part 1 of 2

  • Summary

  • Asembia’s AXS24 Summit, a pinnacle of specialty drug and healthcare discussions, concluded earlier this month. We are thrilled to share that our podcast was selected as a media partner for this esteemed event. This is the first of two episodes dedicated to AXS24, where Scott and Mark had the opportunity to interview several key speakers and attendees. In this episode, we bring you the insights of Melissa Paige, a seasoned healthcare professional and President of the National Association of Medication Access & Patient Advocacy, who led a session on the Patient Financial Impact of IRA. We also present the perspectives of Renee Rayburg, RPh., VP, Clinical Strategy, Pharmaceutical Strategy Group and Morgan Lee, PhD, MPH, CPH, Senior Director, Research & Strategy, PSG, who are renowned for their study and session on Viewpoints in Specialty Drug Benefit Design.

    Melissa Paige, President, (NAMAPA)
    University of Virginia Health System
    Asembia
    Inflation Reduction Act
    Dr. Madelaine Feldman
    Renee Rayburg, Vice President Specialty Clinical Consulting, Artemetrx,
    Morgan Lee, PhD, Senior Director, PSG
    Pharmacy Benefit Managers (PBMs)
    GoodRx
    2024 Trends in Specialty Drug Benefits Report
    Medical terminology referenced in this episode:
    Generic ARBs
    Multiple Sclerosis
    Humira biosimilars
    Albuterol inhaler
    Email us:comments@prescriptionforbetteraccess.com.
    Follow us on X, LinkedIn, YouTube and Threads.

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Interviews from Asembia's AXS24 Summit, Part 1 of 2

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.